NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001740

Registered date:27/02/2009

The healing effect of rebamipide for artificial ulcer after treatment of endoscopic submucosal dissection: a prospective randomized trial

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedEarly gastric cancer, Gastric adenoma
Date of first enrollment2008/11/01
Target sample size100
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Administration of PPI(proton pump inhibitor) plus rebamipide 300mg for 8weeks Administration of PPI for 8weeks after ESD

Outcome(s)

Primary OutcomeThe healing ratio of artificial ulcer at 4weeks after ESD.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaThe patients who: (1)repeat hematemesis, (2) pregnant, (3)has sever liver, renal and cardiopulumonary disease, (4)has allergic drug reaction.

Related Information

Contact

public contact
Name
Address Japan
Telephone
E-mail araara@gifu-u.ac.jp
Affiliation Gifu University Department of Gastroenterology
scientific contact
Name Hiroshi Araki, M.D.,Ph.D.
Address 1-1Yanagito, Gifu city, Gifu prefecture,Japan, 501-1194 Japan
Telephone 058-230-6308
E-mail
Affiliation Gifu University Department of Gastroenterology